Otsuka Pharmaceutical Co. Newsletter
-
ICU Medical and Otsuka Pharmaceutical Factory Partner to Bolster IV Solutions Manufacturing in North America
02 May 2025 20:45 GMT
ICU Medical, Inc. and Otsuka Pharmaceutical Factory announce the formation of …
-
Otsuka Pharmaceutical extends a hand of support to ‘sandwich caregivers’
14 Apr 2025 18:14 GMT
In recent years, Otsuka Pharmaceutical has made a public, concerted …
-
IGALMI Marks Significant Market Growth, Reaching New Heights In Treatment Accessibility Delveinsight
01 May 2025 23:00 GMT
… the key schizophrenia companies, including Otsuka Pharmaceutical Development & Commercialization, Inc., Gedeon …
-
Sky Labs partners with Otsuka Pharmaceutical to expand global distribution of smart ring blood pressure monitor
22 Jan 2025 02:45 GMT
… (MOU) with Japan's Otsuka Pharmaceutical to discuss the overseas distribution … ).
"The partnership discussions with Otsuka Pharmaceutical hold significant potential to impact …
-
Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight
01 May 2025 17:00 GMT
… the key schizophrenia companies, including Otsuka Pharmaceutical Development & Commercialization, Inc., Gedeon …
-
Astex Pharmaceutical takes 19 per cent stake in Mosaic Therapeutics
01 May 2025 09:18 GMT
… , a wholly owned subsidiary of Otsuka Pharmaceutical Co.
Both companies are based … supplier in Japan by 1946. Otsuka Pharmaceutical Co Ltd was officially established …
-
Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition
01 May 2025 01:01 GMT
… tolvaptan, brand name Jynarque, an Otsuka Pharmaceutical drug approved by the FDA …
-
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
30 Apr 2025 15:34 GMT
… . and has limited treatment options. Otsuka Pharmaceutical’s drug, tolvaptan, is approved …
-
Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
29 Apr 2025 17:00 GMT
… companies such as PTC Therapeutics, Otsuka Pharmaceutical, Relief Therapeutics Holding, BioMarin Pharmaceutical …
Key Phenylketonuria Companies: PTC Therapeutics, Otsuka Pharmaceutical, Relief Therapeutics Holding, BioMarin Pharmaceutical …
-
Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in Europe
29 Apr 2025 15:31 GMT
… Knutsford, UK), funded by Otsuka Pharmaceutical Development & Commercialization Inc. … This work was sponsored by Otsuka Pharmaceutical Development & Commercialization … full-time employees of Otsuka Pharmaceutical Development & Commercialization, …